Kawagishi, Naoki
Suda, Goki
Sakamori, Ryotaro
Matsui, Takeshi
Onozawa, Masahiro
Yang, Zijian
Yoshida, Sonoe
Ohara, Masatsugu
Kimura, Megumi
Kubo, Akinori
Maehara, Osamu
Fu, Qingjie
Hosoda, Shunichi
Tokuchi, Yoshimasa
Suzuki, Kazuharu
Nakai, Masato
Sho, Takuya
Morikawa, Kenichi
Natsuizaka, Mitsuteru
Ogawa, Koji
Sakai, Hajime
Ohnishi, Shunsuke
Baba, Masaru
Takehara, Tetsuo
Sakamoto, Naoya
Article History
Received: 17 March 2022
Accepted: 26 September 2022
First Online: 7 October 2022
Competing interests
: Prof. Naoya Sakamoto has received lecture fees from Bristol Myers Squibb and Pharmaceutical K.K., grants and endowments from MSD, K.K., and Chugai Pharmaceutical Co., Ltd., and a research grant from Gilead Sciences Inc. and AbbVie GK. Dr. Goki Suda has received research grants from Merck & Co., Gilead Sciences Inc., and Bristol Myers Squibb. The other authors have no conflicts of interest to disclose.